The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...

Police across Europe have dismantled a dark web drug marketplace known as 'Archetyp Market', the pan-European Europol police ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...

"Transparency is important to us at Wildtype." Wildtype is the third lab-grown meat producer to receive full government ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. | The FDA is introducing a ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...